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Syrigoid carcinomaWe report the case of a SEC of the vulva in a 58-year-old female,
treated in 1996 for a squamous cell carcinoma of the cervix FIGO stage
2b with radical hysterectomy Piver III, external beam radiotherapy to
the pelvis (50 Gy in 25 fractions) delivered by four-ﬁeld box technique
and a parametrial boost.
The patient had been included in a follow up program and since
November 2003 she started annual visits in our department.
The treatment of cervical cancer was complicated by intraoperative
bleeding afterwhich shewas diagnosedwith a deﬁciency of coagulative
factor X (FX 25%). Moreover she developed a mild right lower limb
lymphedema (G1 according to French-Italian glossary of complications)
that disappeared withmassotherapy. The patient had a medical history
signiﬁcant for hypertension and assumedhormone replacement therapy
from 1996 to 2001 to prevent vasomotor and urogenital atrophy
symptoms.
In 2007 she underwent aspiration of a small cyst developed on the
left labia majora. Cytologic examination on the aspirated ﬂuid was
negative for tumor cells.
Following annual visits were always regular until February 2010
when she complained occasional pruritus of left labia majora associ-
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Open access under CC BY-NC-ND license.area of the cysts aspirated 3 years before from which biopsy had
been taken. The urethral meatus, the clitoris as well as the vaginal
vault, were normal. No inguinal lymph nodes were palpable in either
site.
Pap smear and colposcopy were negative while histopathological
ﬁndings on the biopsy revealed epithelial neoplasia of probable
adnexal origin with proliferative index Ki67 about 15%.
In June 2010 the patient underwent wide local excision of the
mass in local anesthesia after infusion of prothrombin complex
concentrate.
Tumor tissue was ﬁxed in 10% neutral buffered formalin and
processed to parafﬁn wax blocks. Parafﬁn wax sections, 5-mm
thick, were cut and were hematoxylin–eosin stained.
The tumor was centred in mid vulvar dermis without contact with
epidermis (Fig. 1). It was characterized by an inﬁltrate of basaloid
cells showing ductural differentiation, set in a dense, hyalinised,
ﬁbrous stroma. The tumor was made up of a mix of epithelial nests
and small ducts syringoma-like (Fig. 2), branching or anastomosing
to form tubuloalveolar structures and solid cords. The epithelial
cells were small with hyperchromatic nuclei with minimal atipia,
ill-deﬁned pale cytoplasm and indistinct cell membrane. Mitotic
activity was low. Vascular and perineural invasion (Fig. 3) were
present.
The ﬁnal pathologic report revealed an eccrine carcinoma of the
vulva with syringomatous features p T1, with signs of perineural
and vascular invasion and free resection margins. Therefore we
radicalized our surgery with left radical vulvectomy and a left inguinal
lymphadenectomy, again after infusion of prothrombin complex
concentrate.
Histopathologic analysis did not reveal the presence of additional
tumor cells and inguinal lymph nodes were negative for tumor: she
deﬁnitely presented an eccrine carcinoma of the vulva with syringo-
matous features FIGO stage I (T1 N0 M0).
The immediate postoperative clinical course was with no
complications and she was discharged after 8 days of hospitalization:
12 days after discharge the patient developed an inguinal lymphocele
and partial vulvar surgical wound dehiscence.
FromSeptember 2010 toOctober 2010 shewas treatedwithVacuum
Assisted Closure therapy with surgical wound healing.
The patientwas addressed to follow up visits every 3 months; 1 year
after last surgical treatment she doesn't have any evidence of relapsing
disease, but developed a moderate left lower limb lymphedema (G2
according to French-Italian glossary of complications).
Fig. 1. The tumor was centred in mid vulvar dermis without contact with epidermis
(original magniﬁcation, ×2).
Fig. 3. Perineural invasion with tumor cells insidiously attached to small nervous twigs
(original magniﬁcation, ×20).
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Among the malignant tumors of the vulva, 85% are of squamous
cell histology. Much more rare forms are basal cell carcinomas,
adenocarcinomas, melanomas, sarcomas and adnexal skin tumors.
Adnexal skin tumors are rare neoplasms that develop from hair
follicles, sebaceous glands and sweat glands. Incidence, classiﬁcation,
diagnosis, and behaviour of sweat gland carcinomas have not been
deﬁnitively clariﬁed (Urso et al., 2001) because of the relative rarity
of such neoplasms, their resemblance to some metastatic visceral
carcinomas, the too-wide range of their histologic appearances,
and the confusing terminology used by various authors (Mehregan
et al., 1983; Wick et al., 1985; Urso et al., 1993). The ﬁrst classiﬁcation
was proposed in 1968 by Berg and McDivitt (1968) and in its general
outline is followed even today. It classiﬁes adnexal skin cancers using
the classiﬁcation of adenomas, so that for every known adenoma
identiﬁes amalignant counterpart (parallel classiﬁcation): e.g. syringoma
and syringomatous carcinoma. Syringomatous carcinoma has a variety
of synonyms or variants including SEC (or eccrine syringomatous
carcinoma), eccrine epithelioma (basal cell tumor with eccrine
differentiation), malignant syringoma, and sweat gland carcinoma
with syringomatous features (Nishizawa et al., 2006).Fig. 2. The tumor wasmade up of amix of epithelial nests and small ducts syringoma-like
(original magniﬁcation, ×20).Histologically, SEC resembles syringoma by presentingwith ductal,
cystic, and tadpole-shaped structures. SEC differs from syringoma by
its cellularity and deep invasiveness. SEC needs to be differentiated
especially from basal cell carcinoma and visceral adenocarcinoma
with skin metastases.
It usually affects subjects in the fourth to seventh decades of life,
and manifests itself as a solitary, ﬁrm nodule or plaque (Nishizawa
et al., 2006).
In front of the vulvar mass our ﬁrst hypothesis were an
HPV-related cancer or a cancer related to previous radiotherapy.
Biopsy allowed instead the diagnosis of SEC and we looked for
suggestions for treatment to be carried out in the medical literature.
A literature search conducted in MEDLINE database looking for SEC
of the vulva returned 0 results.
A hundred examples of SEC have been reported since the initial
report by Freeman andWinkelmann in 1969 (Freeman andWinkelmann,
1969) located on the scalp, extremities, ear, eyebrow, neck, upper lip,
thorax and abdomen (Urso et al., 1993; Nishizawa et al., 2006;
Ahmed et al., 2010) but there have been no previous reports describing
clinical ﬁndings and management of this tumor on the vulva.
The intervention was radicalized analyzing the inguinal lymph
nodes because of the locally aggressive behavior of SEC in other
sites reported by literature.
The role of radiation treatment and chemotherapy for sweat gland
carcinoma are under debate. Some reports suggest at best, a role for
radiotherapy in the local control of the disease (Mertens et al.,
1996; Piedbois et al., 1987).
Our patient had negative inguinal lymph nodes so we decided to
avoid adjuvant therapy.
Our plan with this patient is to carry on with close follow up visits
paying particular attention to any local recurrence of disease.
SEC should be taken into consideration in the differential diagnosis
of vulvar cancer: the contribution of a trained pathologist is essential
to set an appropriate treatment program.
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